Human Chorionic Gonadotropin (hCG) supplied under the designation 'research use only' (RUO) is a purified heterodimeric glycoprotein intended strictly for in vitro assays, cell culture models, and preclinical laboratory experimentation. PX1 Research provides high-purity, USA-manufactured hCG paired with lot-specific analytical validation to support rigorous scientific investigation.
Human Chorionic Gonadotropin (hCG) supplied under the designation 'research use only' (RUO) is a purified heterodimeric glycoprotein intended strictly for in vitro assays, cell culture models, and preclinical laboratory experimentation. PX1 Research provides high-purity, USA-manufactured hCG paired with lot-specific analytical validation to support rigorous scientific investigation.
In contemporary laboratory investigation, the designation 'research use only' (RUO) specifies that a chemical or biological agent is manufactured, tested, and distributed exclusively for non-clinical analytical and experimental applications. When evaluating hCG research use only materials, investigators are accessing a highly characterized heterodimeric glycoprotein intended to serve as a reagent in biochemical assays, receptor-binding studies, and cell line exposures. RUO status dictates that the material must never be administered to human subjects, utilized in diagnostic procedures, or incorporated into therapeutic regimens.
The strict RUO framework ensures that biological compounds maintain precise chemical consistency without the regulatory overhead associated with finished pharmaceutical packaging. For research institutions operating within cell biology, endocrinology, and reproductive physiology, utilizing designated RUO reagents guarantees access to lot-specific analytical documentation—such as HPLC chromatograms and mass spectrometry reports—enabling reproducible experimental conditions across longitudinal study designs.
Human Chorionic Gonadotropin is a complex glycoprotein composed of two non-covalently linked subunits: an alpha (α) subunit consisting of 92 amino acids and a beta (β) subunit comprising 145 amino acids. The α-subunit is structurally identical to that of Luteinizing Hormone (LH), Follicle-Stimulating Hormone (FSH), and Thyroid-Stimulating Hormone (TSH), while the unique carbohydrate side chains and amino acid sequence of the β-subunit confer its specific biological activity and distinct half-life in analytical media.
In preclinical model systems, hCG functions as a potent agonist at the Luteinizing Hormone/Choriogonadotropin Receptor (LHCGR), a G protein-coupled receptor expressed predominantly on steroidogenic cells. Binding of hCG to the extracellular domain of LHCGR triggers a conformational change that activates membrane-bound adenylyl cyclase, initiating intracellular cyclic adenosine monophosphate (cAMP) cascades. Investigators measuring downstream signal transduction utilize this pathway to quantify signal amplification, protein kinase A (PKA) activation, and transcriptional regulation of steroidogenic enzymes in vitro. To explore related signaling cascades in laboratory models, researchers often consult our research library hub.
In vitro models rely heavily on purified gonadotropins to investigate steroidogenesis, gene expression, and cellular differentiation. In primary Leydig cell cultures and immortalized Leydig cell lines (such as MA-10 or TM3), exposure to research-grade hCG induces robust expression of Steroidogenic Acute Regulatory (StAR) protein and cytochrome P450 side-chain cleavage enzyme (CYP11A1). Researchers track these enzyme kinetics to map cholesterol transport mechanisms across the inner mitochondrial membrane.
Similarly, in ovarian granulosa cell assays, hCG is employed to model luteinization and progesterone synthesis downstream of LHCGR stimulation. Preclinical rodent models also utilize exogenous hCG to evaluate follicular development, vascular endothelial growth factor (VEGF) expression, and tissue remodeling mechanisms under controlled laboratory conditions. Experimental data derived from these preclinical setups provide fundamental insights into mammalian endocrine control without confounding clinical variables.
When designing end-point functional assays, investigators frequently compare direct receptor agonists like hCG against upstream hypothalamic peptides. While hCG directly stimulates LHCGR, peptides acting upstream in the hypothalamic-pituitary-gonadal (HPG) axis alter endogenous gonadotropin secretion patterns through distinct signal transduction networks. Understanding these functional differences is critical for selecting the correct reagent for specific research hypotheses.
For instance, researchers evaluating neuroendocrine regulation often compare direct gonadotropin exposure with upstream secretagogues like kisspeptin-10, which activates GPR54 to stimulate native GnRH release. Alternatively, protocols targeting receptor desensitization or steady-state peptide signaling may incorporate continuous or pulsatile administration of gonadorelin or GH-axis modulators like cjc-1295. While hCG acts downstream directly at the target receptor level, these upstream signaling agents provide researchers with tools to interrogate central regulation versus peripheral tissue response.
To preserve the structural integrity of lyophilized glycoproteins, proper laboratory handling protocols must be strictly maintained. Lyophilized hCG is highly stable at reduced temperatures but remains sensitive to thermal fluctuations, shear stress, and improper solvent selection. Upon receipt, unopened vials should be stored in a controlled freezer environment (-20°C or lower) protected from light.
Reconstitution should be performed using sterile, laboratory-grade solvents such as Bacteriostatic Water (containing 0.9% benzyl alcohol) or Sterile Normal Saline, depending on downstream assay compatibility. The solvent should be gently introduced along the inner glass wall of the vial, allowing the cake to dissolve naturally without vigorous vortexing, which can induce protein denaturation and aggregation. Reconstituted aliquots should be divided into single-use volumes and stored at 2°C to 8°C for short-term assays or frozen at -80°C for extended experimental series. Refreeze cycles must be avoided to prevent structural degradation of the tertiary protein conformation.
Experimental reproducibility in peptide and protein research depends fundamentally on source purity. Impurities such as truncated fragments, aggregate species, or residual synthesis reagents can confound cell culture assays and yield inaccurate quantitative data. PX1 Research addresses this critical requirement by subjecting every lot of research peptides to rigorous, independent third-party analytical testing.
Purity is quantitatively validated using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), ensuring that the primary target protein peak achieves defined purity thresholds (typically ≥98%). Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) or Liquid Chromatography-Mass Spectrometry (LC-MS) is simultaneously utilized to verify the exact molecular mass and subunit composition. A lot-specific Certificate of Analysis (COA) detailing these findings is made publicly available for every batch, empowering researchers to verify sequence identity and molecular weight prior to initiating in vitro trials.
Endotoxin contamination represents a severe variable in cell line experimentation. Lipopolysaccharides (LPS) derived from Gram-negative bacterial cell walls can trigger non-specific inflammatory signaling pathways, upregulating NF-κB and altering baseline cytokine expression in primary cell cultures. Consequently, analytical compounds intended for delicate in vitro assays must maintain rigorously low endotoxin limits.
PX1 Research enforces strict endotoxin screening using Chromogenic Recombinant Factor C (rFC) or Limulus Amebocyte Lysate (LAL) assays. Materials are verified to fall well below standard laboratory action limits (typically <0.01 EU/μg of protein). Operating out of GMP-compliant facilities utilizing ISO 17025 accredited analytical validation, PX1 Research provides biological reagents that eliminate biological confounders, ensuring that observed cellular responses are attributable solely to the targeted compound.
The integrity of scientific research relies heavily on supply chain transparency. Overseas sourcing of unverified biochemicals often introduces lot-to-lot variability, uncharacterized counter-ions, and inconsistent storage conditions during transit. Sourcing research compounds manufactured in the USA guarantees strict adherence to quality control systems, standardized synthesis methodologies, and immediate cold-chain fulfillment.
PX1 Research operates centralized distribution hubs out of California and Arizona, providing same-day dispatch for orders finalized prior to daily cutoff times (Monday through Friday). By maintaining complete domestic supply chain oversight, research facilities, academic laboratories, and commercial institutions enrolled in our wholesale account portal receive stable, fully traceable compounds optimized for sensitive assay environments.
What does the 'Research Use Only' (RUO) statement mean for hCG?
The RUO designation indicates that the compound is synthesized and characterized strictly for laboratory experimentation, in vitro assays, and preclinical research. It is explicitly not cleared, labeled, or intended for human use, veterinary administration, or diagnostic procedures.
How does hCG interact with cell surface receptors in laboratory models?
hCG acts as an agonist at the Luteinizing Hormone/Choriogonadotropin Receptor (LHCGR). In vitro binding activates adenylyl cyclase via Gs protein coupling, elevating intracellular cAMP levels and downstream protein kinase A (PKA) signaling in target cell lines.
What purity verification is provided with PX1 Research hCG?
Every lot of hCG from PX1 Research undergoes independent third-party testing via RP-HPLC to confirm purity (≥98%) and Mass Spectrometry (LC-MS/MALDI-TOF) to verify exact molecular weight. Lot-specific Certificates of Analysis (COAs) are accessible for review.
What solvent is recommended for reconstituting lyophilized hCG for lab assays?
Reconstitution is typically carried out using sterile laboratory-grade Bacteriostatic Water or Sterile 0.9% Sodium Chloride, depending on the requirements of the downstream protocol. Diluents should be added gently along the vial wall to prevent protein aggregation.
How should reconstituted hCG be stored to maintain enzymatic stability?
Once reconstituted, liquid solutions should be kept at 2°C to 8°C for short-term work. For long-term storage, aliquots should be frozen at -80°C to minimize degradation and avoid repeated freeze-thaw cycles.
Why is endotoxin testing critical for hCG used in cell cultures?
Bacterial endotoxins (LPS) can induce inflammatory signals in cell cultures, skewing experimental results. PX1 Research screens compounds using LAL/rFC assays to ensure endotoxin levels remain below stringent research thresholds (<0.01 EU/μg).
How does hCG differ from GnRH agonists in preclinical experimental designs?
hCG directly stimulates peripheral target cell receptors (LHCGR), whereas GnRH agonists act centrally on pituitary gonadotropes to regulate endogenous LH and FSH release. They test different levels of the neuroendocrine axis.
Where is PX1 Research hCG manufactured and shipped from?
PX1 Research compounds are manufactured in USA-based, GMP-compliant facilities and fulfilled directly from fulfillment centers located in California and Arizona with same-day shipping available M–F.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.